A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID ‐19 years
European Journal of Neurology · 2024
DOI: 10.1111/ene.16439 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Marina Blanco-Ruiz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Universitario Torrecárdenas, Almeria, Spain. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GBS/CIDP Foundation International, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background and purpose The purpose was to perform a nationwide epidemiological study of Guillain–Barré syndrome (GBS) in Spain, analysing background incidences and seasonal variation and trying to identify incidence changes during the coronavirus disease 2019 (COVID‐19) years.
Methods
This was an observational study collecting all GBS diagnoses from the National Epidemiological Surveillance Network collected by the Ministry of Health. Patients discharged with GBS as the main diagnosis and admitted during 2018–2021 were included. Data on the incidence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections were obtained from the National Epidemiology Centre.
Results
In total, 3147 cases were included, 832 in 2018, 861 in 2019, 670 in 2020 and 784 in 2021. Nationwide hospital incidence was 1.78 in 2018, 1.71 in 2019, 1.41 in 2020 and 1.66 in 2021, with an increased frequency in males, the elderly population and in the winter season. Eleven per cent of GBS patients needed ventilatory support. GBS and SARS‐CoV‐2 incidences did not correlate with one another ( r = −0.29, p = 0.36). GBS incidence decreased during 2020 and during the COVID‐19 lockdown period in comparison to the same months of 2018–2019.
Conclusions
The incidence of GBS in Spain is similar to that of other countries. Despite prior reports describing a significant increase in COVID‐19‐associated GBS in Spain, a significant drop of GBS incidence during the SARS‐CoV‐2 pandemic was detected, probably due to prevention measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hospital Universitario Torrecárdenas, Almeria, Spain.
- Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.
ORCID-Profile: Lorena Martín-Aguilar, Elba Pascual-Goñi, Elena Cortés, Luis Querol
Förderung
- GBS/CIDP Foundation International
- Instituto de Salud Carlos III
Zitieren
APA
Blanco-Ruiz, M., Martín-Aguilar, L., Caballero-Ávila, M., Lleixà, C., Pascual-Goñi, E., Collet-Vidiella, R., Tejada-Illa, C., Turon-Sans, J., Carbayo, Á., Llansó, L., Cortés, E., Amaya Pascasio, L., & Querol, L. (2024). A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID ‐19 years. European Journal of Neurology. https://doi.org/10.1111/ene.16439
Vancouver
Blanco-Ruiz M, Martín-Aguilar L, Caballero-Ávila M, Lleixà C, Pascual-Goñi E, Collet-Vidiella R, et al. A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID ‐19 years. European Journal of Neurology. 2024. doi:10.1111/ene.16439
BibTeX
@article{BlancoRuiz2024,
author = {Blanco-Ruiz, Marina and Martín-Aguilar, Lorena and Caballero-Ávila, Marta and Lleixà, Cinta and Pascual-Goñi, Elba and Collet-Vidiella, Roger and Tejada-Illa, Clara and Turon-Sans, Janina and Carbayo, Álvaro and Llansó, Laura and Cortés, Elena and Amaya Pascasio, Laura and Querol, Luis},
title = {A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID ‐19 years},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16439}
}
EUVIMED